Clinical trials: Weakness
Generalized Myasthenia Gravis
An Efficacy and Safety Study of ARGX-113 in Patients With Myasthenia Gravis Who Have Generalized Muscle Weakness
A randomized, double-blind, placebo controlled, multicenter Phase 3 trial to evaluate the efficacy, safety, tolerability, quality of life and impact on normal daily activities of ARGX-113 in patients with gMG.
- Trial name
- ADAPT (NCT03669588)
- Testing
- ARGX-113
- Where
- 66 sites in United States, Belgium and 14 more
- Volunteers
- 167 people
- Sponsor
- argenx
Limb Loss, Limb Weakness
Analysis of Human Movement With Assistive Devices
The purpose of this research is to evaluate how people move about in different settings with different assistive devices or components, and to understand how people interact with different assistive technologies.
- Conditions
- Limb Loss, Limb Weakness, Limb Paralysis, Movement Disorders
- Trial name
- NCT05729061
- Testing
- Assist-Knee, Prosthetic Knee, Prosthetic Ankle
- Where
- United States
- Volunteers
- 100 people, healthy volunteers welcome
- Sponsor
- Orthocare Innovations, LLC